Moira Rushton - Div Med Oncol, Ottawa Hosp

基本信息

浏览量：9

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 31 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

REaCT 5G: A Randomized Study Comparing Bone Pain after 5 Days of Filgrastim or One Day of Pegfilgrastim for Primary Febrile Neutropenia Prophylaxis During Neo-/Adjuvant Chemotherapy for Early Breast Cancer

Terry Ng, Yuxin Zhang,Carol Stober, Jennifer Shamess,Natalie Mills,Stuart Nicholls,Mohammed Ibrahim, Daniel Davoudpour, Christopher Armiento,Marie-France Savard,Moira Rushton,Arif Awan,Sandeep Sehdev,John Hilton,Xinni Song,Rakesh Goel,Fiona Macdonald,Kelly Daigle,Lisa Vandermeer,Monica Taljaard, Mark Clemons

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

A Multicenter Physician Survey Evaluating the Use of Ki-67 in Breast Cancer Management in Canada

Jennifer Leigh, Sharon F. McGee,Lisa Vandermeer,Phillip Williams,Moira Rushton

Biomedicinesno. 11 (2024): 2471

引用0浏览0引用

Abstract PO2-12-12: REaCT 5G: A Randomized Study Comparing Bone Pain after 5 Days of Filgrastim or One Day of Pegfilgrastim for Primary Febrile Neutropenia Prophylaxis During Neo-/Adjuvant Chemotherapy for Early Breast Cancer

Cancer Researchno. 9_Supplement (2024): PO2-12

引用0浏览0引用

A phase II study of CFI-400945 in patients with advanced/metastatic cancer: Canadian Cancer Trials Group (CCTG) IND.237

David W. Cescon,John Hilton,Philippe Bedard,Phillip Blanchette,Rossanna C. Pezo, Ayesha Bashir,Vikaash Kumar,Terry L. Ng,Arif Awan,Anthony Lott,Jacques Antoun Raphael,Linda Hagerman, Mark Bray,Lindsay Muyot,Jesus Fuentes Antras,Lesley Seymour,Dongsheng Tu,Pierre-Olivier Gaudreau,Moira Rushton

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Abstract P3-07-14: A Phase II Study of CFI-400945 in Patients with Advanced/metastatic Cancer: Canadian Cancer Trials Group (CCTG) IND.237

Cancer researchno. 5_Supplement (2023): P3-14

引用0浏览0引用

Management of Genitourinary Symptoms in Patients with Breast Cancer: an Updated Systematic Review of Available Evidence from Randomized Trials

Parvaneh Fallah,Dianna Wolfe,Brian Hutton,Mark Clemons,Risa Shorr,Lisa Vandermeer,Moira Rushton

Supportive care in cancer（2023）

引用1浏览0引用

A Phase II Single-Arm, Open-Label Trial of T-DM1 (Ado-Trastuzumab Emtansine) and Neratinib for HER2-positive Breast Cancer with Molecular Residual Disease (KAN-HER2 MRD)

Mitchell Elliott,Jesus Fuentes Antras,Philippe Echelard,Nicholas Meti,Alisa Nguyen, Michelle Liu, Carolina Sanabria Salas,Christopher Gareth Smith,Moira Katherine Rushton,Lillian L. Siu,Hal K. Berman,Philippe L. Bedard,David W. Cescon

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Prospective ctDNA genotyping for treatment selection in metastatic castration-resistant prostate cancer (mCRPC): The Canadian Cancer Trials Group phase II PC-BETS umbrella study

Edmond Michael Kwan,Moira Katherine Rushton,Wilson Tu,Sebastien J. Hotte,Som D. Mukherjee,Michael Ong,Michael Paul Kolinsky,Zineb Hamilou,Eric Winquist,Cristiano Ferrario,Robyn Jane Macfarlane, Fred Saad, Muhammad Salim,Di Maria Jiang,Dongsheng Tu, James Hutchenreuther,Matti Annala,Lesley Seymour,Kim N. Chi, Alexander William Wyatt

Journal of Clinical Oncologyno. 6_suppl (2023): 218-218

引用0浏览0引用

CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)

John Hilton,David W. Cescon,Andrew Robinson,Sukhbinder Dhesy-Thind,Sara Taylor,Arif Awan,Terry L. Ng,Moira Rushton,Marie-France Savard,Lindsay Muyot, Marie Claude Reeves,Linda Hagerman,Hongbo Lui, Mark Bray,Dongsheng Tu,Lesley Seymour,Pierre-Olivier Gaudreau

CANCER RESEARCHno. 5 (2023)

引用0浏览0引用

Young Women with Breast Cancer: The Current Role of Precision Oncology

Amirrtha Srikanthan,Arif Ali Awan,Sharon McGee,Moira Rushton

Journal of Personalized Medicineno. 11 (2023): 1620

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn